A study led by Columbia obstetricians has shown that a new device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in a wide range of patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
Columbia researchers have uncovered how Gram-negative bacteria—which cause a variety of drug-resistant infections—build their protective outer layer, which could lead to more effective treatments.
COVID patients who remain unresponsive after receiving respiratory support may require long time periods to regain consciousness; delays are related to blood oxygen levels.
Two early-career scientists at Columbia University Vagelos College of Physicians and Surgeons—Minoree Kohwi, PhD, and Chao Lu, PhD—have been awarded prestigious 2022 Hirschl Trust Research Awards.
What was learned by researchers during the pandemic has changed the mindset for scientists: “Why do we have to follow the old routine when we see a new paradigm working so well?”
COVID vaccines and monoclonal antibody treatments offer less protection against new omicron subvariants, a new study from researchers at Columbia and University of Hong Kong finds.
By applying artificial intelligence to standard-of-care imaging, Columbia cancer researchers can predict how well immunotherapy will work for patients with melanoma.
An over-the-counter cough suppressant can knock some heart cells back into rhythm, a finding that may lead to a new way to treat a rare heart condition.
A study of weight loss methods suggests that gastric bypass surgery is the best strategy for patients with type 2 diabetes and severe obesity, regardless of the severity of a patient’s diabetes.